主要收入构成
报告期：2026-06-30
| 主营产品构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 感冒药 |
5.88% |
341.05 |
-13.73% |
180.05 |
47.21% |
2.82% |
| 抗病毒抗感染 |
13.61% |
790.22 |
-20.99% |
601.47 |
23.89% |
-7.72% |
| 抗肿瘤 |
5.18% |
300.65 |
5.01% |
83.02 |
72.39% |
-1.04% |
| 其他（补充） |
1.09% |
63.24 |
11.28% |
11.25 |
82.21% |
4.47% |
| 其它 |
6.55% |
380.15 |
20.06% |
203.28 |
46.53% |
1.40% |
| 消化系统 |
3.16% |
183.30 |
-6.33% |
91.84 |
49.90% |
-1.79% |
| 心脑血管 |
4.97% |
288.20 |
-12.62% |
86.71 |
69.91% |
-0.35% |
| 营养补充剂 |
59.57% |
3457.88 |
-7.85% |
1208.80 |
65.04% |
-2.12% |
| 总计 |
5804.70 |
| 行业收入构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 保健品 |
15.05% |
2429.43 |
-6.93% |
987.59 |
59.35% |
-3.83% |
| 分部间抵消 |
-- |
-179.83 |
-- |
-172.44 |
4.11% |
-- |
| 化学制剂 |
13.70% |
2212.16 |
-13.82% |
917.02 |
58.55% |
0.56% |
| 零售 |
12.68% |
2047.21 |
21.04% |
1734.86 |
15.26% |
-0.84% |
| 批发商业客户 |
14.03% |
2265.15 |
0.08% |
2185.83 |
3.50% |
0.07% |
| 批发医疗客户 |
36.89% |
5954.85 |
-0.16% |
5545.61 |
6.87% |
-0.85% |
| 其他 |
0.45% |
71.98 |
-18.06% |
55.55 |
22.82% |
-0.16% |
| 其他(补充) |
0.39% |
63.24 |
11.28% |
11.25 |
82.21% |
4.47% |
| 其它 |
0.55% |
89.16 |
106.79% |
87.99 |
1.31% |
58.68% |
| 生物制剂 |
1.82% |
293.30 |
4.83% |
80.02 |
72.72% |
-0.98% |
| 原料药 |
0.02% |
3.49 |
-44.22% |
3.28 |
6.03% |
-30.77% |
| 中药 |
4.42% |
713.91 |
-7.28% |
379.27 |
46.87% |
-2.03% |
| 总计 |
15964.06 |
| 地区收入构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 境内 |
92.64% |
7685.26 |
3.66% |
5840.26 |
24.01% |
0.02% |
| 境外 |
7.36% |
610.39 |
-14.09% |
267.01 |
56.26% |
-2.64% |
| 总计 |
8295.66 |
